Indian drug regulators have announced that they have allowed emergency use of two vaccines, including a new coronavirus vaccine developed by British pharmaceutical giant AstraZeneca and others.
Indian drug regulators held a meeting on the 3rd to discuss the new coronavirus vaccine, a vaccine developed by AstraZeneca and Oxford University and a vaccine developed by the local vaccine production company "Bharat Biotech". Announced that it allowed a type of emergency use.
The cumulative number of infected people has exceeded 10 million, and it is the first time that the vaccine has been approved in India, which is the second largest in the world after the United States.
The Indian government will soon start vaccination from medical workers and others, and will inoculate 300 million people by the summer, Prime Minister Modi wrote on Twitter that "it is a decisive turning point to strengthen the fight." We welcomed the announcement.
The vaccine developed by AstraZeneca and others was approved by the British government on December 30, and in India, the local vaccine production giant "Serum Institute of India" has signed a contract with AstraZeneca and others, and it has already been done. It produces about 50 million vaccines.
The company plans to increase production to 100 million times a month by the end of the year.